SCHEMBL661206

SCHEMBL661206

O=C(CN1C=CCC(c2cc(-c3cccc(O)c3)no2)=C1)c1cccs1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B1 P14061 1/20 0.42
HSD17B2 P37059 1/20 0.42
NPC1 O15118 5/20 0.37
RAB9A P51151 4/20 0.37
ALDH1A1 P00352 4/20 0.37
TP53 P04637 4/20 0.37
MAPK1 P28482 3/20 0.37
SMN1; SMN2 Q16637 3/20 0.37
HPGD P15428 2/20 0.37
TSHR P16473 2/20 0.37
NFKB1 P19838 1/20 0.37
NFKB2 Q00653 1/20 0.37
RELA Q04206 1/20 0.37
MLLT1 Q03111 5/20 0.35
MAPT P10636 3/20 0.34
MLLT3 P42568 1/20 0.34
ALOX15 P16050 1/20 0.34
HSD17B10 Q99714 1/20 0.34
THRB P10828 1/20 0.34
HSD17B13 Q7Z5P4 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL659986 0.87 NPC1 (0.35) NPC1RAB9AALDH1A1TP53MAPK1
SCHEMBL298058 0.78 CHRM2 (0.44) HSD17B1HSD17B2NPC1RAB9AALDH1A1
SCHEMBL287429 0.75 NPSR1 (0.36) NPC1RAB9AALDH1A1TP53MAPK1
SCHEMBL297726 0.73 MAPT (0.38) NPC1RAB9AALDH1A1TP53MAPK1
SCHEMBL298661 0.72 KMT2A (0.37) NPC1RAB9AALDH1A1MAPK1SMN1; SMN2
SCHEMBL7808911 0.69 ALDH1A1 (0.48) NPC1RAB9AALDH1A1MAPK1SMN1; SMN2
SCHEMBL661687 0.68 ERCC5 (0.43) NPC1RAB9AALDH1A1TP53MAPK1
SCHEMBL660685 0.68 ALDH1A1 (0.40) NPC1RAB9AALDH1A1TP53MAPK1
SCHEMBL660093 0.68 ALDH1A1 (0.44) NPC1RAB9AALDH1A1MAPK1SMN1; SMN2
SCHEMBL5728908 0.68 HSD17B1 (0.84) HSD17B1HSD17B2NPC1RAB9AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120046317-A1 NOVEL HETEROCYCLIC COMPOUNDS DUTT CHAITANYA (IN) 2012-02-23 US claimed
US-20120046317-A1 NOVEL HETEROCYCLIC COMPOUNDS DUTT CHAITANYA (IN) 2012-02-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120046317-A1 NOVEL HETEROCYCLIC COMPOUNDS AGER, REN, AGT HSD17B1 2273/4885HSD17B2 2995/4885NPC1 1176/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.